Log in to search using one of your social media accounts:

 

Increasing Acai Sales Demands Vigilance for Chagas Disease Increasing Acai Sales Demands Vigilance for Chagas Disease
Every year, Brazil registers between 110 and 150 new cases of the disease. Confirmation of oral transmission involves a parasitologic examination and epidemiologic evidence.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Discovering potential therapeutic protein inhibitors for Chagas disease
(Tokyo Institute of Technology) Scientists at Tokyo Institute of Technology (Tokyo Tech), Nagasaki University have identified four potential protein inhibitors and unlocked drug discovery strategies for the treatment of Chagas disease by using advanced three-dimensional computer simulation by supercomputer TSUBAME in combination with in vitro experiments and X-ray crystallography. Through this " smart drug discovery " in which IT drug discovery and biochemical experiments cooperate, they identified hit compounds for target protein with a hit rate of 20 times or more than conventional High Throughput Screening (HT...
Source: EurekAlert! - Medicine and Health - September 26, 2017 Category: International Medicine & Public Health Source Type: news

Scientists identify new hosts for Chagas Disease vectors
(University of California - Riverside) Solitary weasel-like animals called tayra might look pretty harmless, but some may actually be incubators for a parasite that causes Chagas disease, a chronic, debilitating condition that is spread by insects called kissing bugs and affects more than 8 million people worldwide. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 18, 2017 Category: Infectious Diseases Source Type: news

Abbott Prism Chagas
The ABBOTT PRISM Chagas assay is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of antibodies to Trypanosoma cruzi (T cruzi), the causative agent of Chagas disease, in human serum and plasma specimens. (Source: What's New at CBER)
Source: What's New at CBER - September 11, 2017 Category: Biomedical Science Source Type: news

Drug For 'Neglected' Chagas Disease Gains FDA Approval Amid Price Worries
U.S. doctors treating Chagas disease have long wanted FDA approval for a treatment that's widely used in Latin America. But when Martin Shkreli took interest, those doctors panicked — then mobilized.(Image credit: Ray Coleman/Science Source) (Source: NPR Health and Science)
Source: NPR Health and Science - September 10, 2017 Category: Consumer Health News Authors: Courtney Columbus Source Type: news

Drug to Treat Chagas Disease to Become Available in the U.S.
Press releaseDrug to Treat Chagas Disease to Become Available in the U.S.August 31, 2017Pharmaceutical company Chemo Group announced today that it will make a drug to treat the neglected tropical disease Chagas available to people in the United States. The U.S. Food and Drug Administration ’s (FDA) approval of the drug, benznidazole, means that Chagas pediatric patients in the U.S. could receive access to a therapy that Doctors Without Borders/Médecins Sans Frontières (MSF) has been using for decades to treat people living with Chagas across Latin America. Though Chagas affects an estimated 300,000 peop...
Source: MSF News - August 31, 2017 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news

U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease
WASHINGTON D.C., BUENOS AIRES, Argentina, MADRID and GENEVA, August 31, 2017 -- (Healthcare Sales & Marketing Network) -- On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research's New Drug Application (NDA) for benznidazole. Th... Biopharmaceuticals, FDA Chemo Group, benznidazole, Chagas disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves First U.S. Treatment for Chagas Disease (FREE)
By the Editors The FDA has approved benznidazole to treat Chagas disease, a parasitic infection, in children aged 2 to 12 years.The disease … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 30, 2017 Category: Primary Care Source Type: news

FDA Approves 1st Treatment for'Kissing Bug' Illness in Children
Benznidazole becomes the nation's only drug for Chagas disease Source: HealthDay Related MedlinePlus Pages: Chagas Disease, Children's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 30, 2017 Category: Consumer Health News Source Type: news

FDA approves first U.S. treatment for Chagas disease
The U.S. Food and Drug Administration has granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease. Chagas disease, or American trypanosomiasis, is a parasitic infection caused by Trypanosoma cruzi and can be transmitted through different routes, (Source: World Pharma News)
Source: World Pharma News - August 30, 2017 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

That drug meant to transform Martin Shkreli's former Bay Area company? Someone else got to it first
A Peninsula company once led by "pharma bad boy" Martin Shkreli had hoped to bring this drug to the United States to treat Chagas disease. A group of for-profit and non-profit interests beat it to the punch. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 30, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

That drug meant to transform Martin Shkreli's former Bay Area company? Someone else got to it first
A Peninsula company once led by "pharma bad boy" Martin Shkreli had hoped to bring this drug to the United States to treat Chagas disease. A group of for-profit and non-profit interests beat it to the punch. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 30, 2017 Category: Health Management Authors: Ron Leuty Source Type: news

FDA Approves Benznidazole, First US Drug for Chagas Disease FDA Approves Benznidazole, First US Drug for Chagas Disease
Benznidazole is indicated for treatment of children aged 2 to 12 years with Chagas disease.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 29, 2017 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

FDA approves first U.S. treatment for Chagas disease
The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 29, 2017 Category: American Health Source Type: news

FDA Approves Benznidazole as First U.S. Treatment for Chagas Disease
August 29, 2017 -- The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 29, 2017 Category: Drugs & Pharmacology Source Type: news

Pharma bad boy Martin Shkreli is gone, but 2 companies spar over drug he snagged
"Pharma bro" Shkreli brought the Chagas disease drug to KaloBios Pharmaceuticals, but a lawsuit claims it has cost more to develop the drug than was represented. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 4, 2017 Category: Health Management Authors: Ron Leuty Source Type: news

Pharma bad boy Martin Shkreli is gone, but 2 companies spar over drug he snagged
"Pharma bro" Shkreli brought the Chagas disease drug to KaloBios Pharmaceuticals, but a lawsuit claims it has cost more to develop the drug than was represented. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 4, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

Pharma bad boy Martin Shkreli is gone, but 2 companies spar over drug he snagged
"Pharma bro" Shkreli brought the Chagas disease drug to KaloBios Pharmaceuticals, but a lawsuit claims it has cost more to develop the drug than was represented. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 4, 2017 Category: Health Management Authors: Ron Leuty Source Type: news

Pharma bad boy Martin Shkreli is gone, but 2 companies spar over drug he snagged
"Pharma bro" Shkreli brought the Chagas disease drug to KaloBios Pharmaceuticals, but a lawsuit claims it has cost more to develop the drug than was represented. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 4, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

Chagas Disease in the United States: Improving Patient Diagnosis and Treatment
September 14, 2017 Bronx, NY.(Montefiore Albert Einstein College of Medicine) (Source: PHPartners.org)
Source: PHPartners.org - August 2, 2017 Category: International Medicine & Public Health Source Type: news

UTEP Scientists awarded patent for Chagas disease vaccine
(The University of Texas at El Paso) A pair of scientists at The University of Texas at El Paso is one step closer to developing the first ever clinical Chagas disease vaccine.Researchers Rosa Maldonado, Ph.D., and Igor Almeida, Ph.D., both faculty in the Department of Biological Sciences, recently were granted a patent for " Mucin-Associated Surface Protein As Vaccine Against Chagas Disease. " (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2017 Category: Infectious Diseases Source Type: news

Autochthonous Transmission of Trypanosoma cruzi to Humans Autochthonous Transmission of Trypanosoma cruzi to Humans
What do we currently know about the autochthonous transmission of Chagas disease caused by T cruzi in the United States?Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 29, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Increased Mortality in Blood Donors Positive for Chagas Disease Increased Mortality in Blood Donors Positive for Chagas Disease
Blood donors seropositive for Chagas disease, a result of infection with Trypanosoma cruzi, have a risk of death more than twice as high as that of similar seronegative donors, according to a death certificate linkage study from Brazil.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 22, 2017 Category: Pathology Tags: Infectious Diseases News Source Type: news

Deaths from Chagas disease under-reported
Chagas disease, affecting millions of people in Central and South America, is classified as one of the 17 most important neglected diseases by the World Health Organization. Now, researchers have found that even the non-symptomatic stage of Chagas infection, which can last for many years, more than doubles a person's risk of death. The new study also concludes that deaths from Chagas have likely been under-reported in the past. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 18, 2017 Category: Science Source Type: news

Deaths from Chagas disease under-reported
(PLOS) Chagas disease, affecting millions of people in Central and South America, is classified as one of the 17 most important neglected diseases by the World Health Organization. Now, researchers have found that even the non-symptomatic stage of Chagas infection, which can last for many years, more than doubles a person's risk of death. The new study, published in PLOS Neglected Tropical Diseases, also concludes that deaths from Chagas have likely been under-reported in the past. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 18, 2017 Category: Infectious Diseases Source Type: news

Merck partners with University of California, San Diego (UCSD) to fight Neglected Tropical Diseases
Merck, a leading science and technology company, today announced that it has agreed with the University of California, San Diego (UCSD) to share compounds under the WIPO Re:Search open innovation umbrella, thereby deepening its efforts in the fight against Neglected Tropical Diseases (NTDs) to identify potential cures for leishmaniasis, Chagas disease (American trypanosomiasis) and human African trypanosomiasis (HAT, sleeping sickness). (Source: World Pharma News)
Source: World Pharma News - April 20, 2017 Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news

Chagas Disease Presents Public Health Challenge in the U.S.
Without early treatment, Chagas disease can cause heart failure (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 20, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Infections, Internal Medicine, Nursing, Pathology, Pulmonology, Institutional, Source Type: news

Illness from'Kissing Bug' Now Widespread in U.S.
Without early treatment, Chagas disease can cause heart failure Source: HealthDay Related MedlinePlus Page: Chagas Disease (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 18, 2017 Category: Consumer Health News Source Type: news

Illness From'Kissing Bug' Now Widespread in U.S.
TUESDAY, April 18, 2017 -- It's spread by an insect that's often called the " kissing bug. " And now, the parasitic infection know as Chagas disease is prevalent in the United States, new research shows. Investigators tested nearly 5,000 Latin... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 18, 2017 Category: Journals (General) Source Type: news

Chagas disease: The Brazilian forest bites back
Bugs that lost their natural habitat through deforestation in the Amazon region are spreading disease in human settlements (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 18, 2017 Category: Pharmaceuticals Source Type: news

Disease Burden Growing as Vector Insects Adapt to Climate Change
Dry drains will reduce the numbers of mosquitoes breeding, but now the Aedes aegypti mosquito is going underground to breed underground in available water and flying to feed. Credit: Zadie Neufville/IPSBy Zadie NeufvilleKINGSTON, Jamaica, Apr 18 2017 (IPS)There were surprised gasps when University of the West Indies (UWI) Professor John Agard told journalists at an Intergovernmental Panel on Climate Change (IPCC) meeting in late November 2016 that mosquitoes were not only living longer, but were “breeding in septic tanks underground”.For many, it explained why months of fogging at the height of Zika and Chikung...
Source: IPS Inter Press Service - Health - April 18, 2017 Category: Global & Universal Authors: Zadie Neufville Tags: Caribbean Climate Wire Climate Change Featured Headlines Health Latin America & the Caribbean Projects Water & Sanitation Chagas Disease Intergovernmental Panel on Climate Change (IPCC) mosquitoes Zika Virus Source Type: news

First large-scale survey of Chagas disease in the United States confirms that the'silent killer' is a major public health challenge for the country
A study of almost 5,000 Latin American-born residents of Los Angeles County found that 1.24 percent tested positive for Chagas disease, a parasitic infection that can cause life-threatening heart damage if not treated early. Chagas disease is one of the leading causes of heart failure in Latin America. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 13, 2017 Category: Science Source Type: news

First large-scale survey of Chagas disease in the United States confirms that the 'silent killer' is a major public health challenge for the country
(Drugs for Neglected Diseases Initiative) A study of almost 5,000 Latin American-born residents of Los Angeles County found that 1.24 percent tested positive for Chagas disease, a parasitic infection that can cause life-threatening heart damage if not treated early. Chagas disease is one of the leading causes of heart failure in Latin America. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 13, 2017 Category: Infectious Diseases Source Type: news

Negative regulator stops extreme immune response to parasite, averting multi-organ damage
(Osaka University) A new study from Osaka University identified a role for the BATF2 protein in negatively regulating the immune response to infection by the protozoan parasite Trypanosoma cruzi, which is responsible for Chagas disease. BATF2 was shown to inhibit production of the IL-23 cytokine, thus limiting immunopathology mediated by another cytokine, IL-17. This furthers understanding of the host response to parasitic infection, and is likely to be applicable to other immune disorders. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 3, 2017 Category: Biology Source Type: news

[Report] Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites
We report a way to selectively kill Trypanosoma by blocking glycosomal/peroxisomal import that depends on the PEX14-PEX5 protein-protein interaction. We developed small molecules that efficiently disrupt the PEX14-PEX5 interaction. This results in mislocalization of glycosomal enzymes, causing metabolic catastrophe, and it kills the parasite. High-resolution x-ray structures and nuclear magnetic resonance data enabled the efficient design of inhibitors with trypanocidal activities comparable to approved medications. These results identify PEX14 as an “Achilles’ heel” of the Trypanosoma suitable for the de...
Source: ScienceNOW - March 31, 2017 Category: Science Authors: M. Dawidowski Source Type: news

Daiichi Sankyo announces collaborative research on drugs for neglected tropical diseases
Daiichi Sankyo Company, Limited (Daiichi Sankyo), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (DNDi) with regard to a new research program, the Hit-to-Lead Project, with the aim of developing drug treatments for two neglected tropical diseases (NTDs), leishmaniasis and Chagas disease. (Source: World Pharma News)
Source: World Pharma News - March 30, 2017 Category: Pharmaceuticals Tags: Featured Daiichi Sankyo Business and Industry Source Type: news

Scientists effectively disrupt communication between parasites that spread disease
A new intervention to tamper with parasites'communication system may lead to the development of drugs to treat, and prevent the spread of, devastating diseases such as African sleeping sickness, leishmaniasis and Chagas'disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 9, 2017 Category: Science Source Type: news

Global Vector Control Response
World Health Organization. 12/05/2016 This five-page report describes the vector-borne diseases that pose a major threat to the health of societies around the world, including malaria, dengue, Zika virus, chikungunya, lymphatic filariasis, onchocerciasis, Chagas disease, leishmaniasis, yellow fever, and Japanese encephalitis. It details the draft Global Vector Control Response 2017-2030, which aims to support countries in mounting coherent and coordinated efforts to counter the increasing burden and threat of vector-borne diseases. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 26, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Targets and patented drugs for chemotherapy of Chagas disease
(Bentham Science Publishers) Chagas disease is a parasitic infection typically spread by triatomine vectors, affecting millions of people all over Latin America. Existing chemotherapy is centered on benznidazole and nifurtimox, providing unsatisfactory results and substantial side effects. The transmission of the disease by people migration has determined the emergence as a public health problem elsewhere in non-endemic countries of the word. So, the finding of novel ways to challenge this neglected disease is a main priority. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 16, 2017 Category: Cancer & Oncology Source Type: news

IDRI contributes to first point-of-care Chagas disease diagnostic for US
(Infectious Disease Research Institute) With Chagas disease becoming more prevalent in the United States, a diagnostic to quickly and easily detect infection is needed. Today, IDRI (Infectious Disease Research Institute) announces that a fusion antigen it developed and patented is being used as part of a Chagas disease diagnostic test created by InBios and recently approved by the US Food& Drug Administration (FDA) for use in the United States. This marks the first point-of-care diagnostic test for Chagas disease available in the United States. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 12, 2017 Category: Global & Universal Source Type: news

Ancient DNA reveals genetic legacy of pandemics in the Americas
Geneticists are exploring how disease introduced by European colonists shaped the evolution of indigenous peoples of the AmericasPrehistoric America was not a disease-free utopia.Tuberculosis, treponemal disease, Chagas disease, and many other pathogens were endemic to populations in different regions of the continent. But the“Columbian Exchange” beginning in 1492 introduced new pathogens to American populations, including smallpox, measles, influenza, and yellow fever. This introduction had devastating consequences for tribes. In some places, death from infectious disease resulted in thedepopulation of entire ...
Source: Guardian Unlimited Science - December 19, 2016 Category: Science Authors: Jennifer Raff Tags: Archaeology Science Genetics Biology Americas Epidemics Indigenous peoples Source Type: news

18 Diseases The World Has Turned Its Back On
This article is part HuffPost’s Project Zero campaign, a yearlong series on neglected tropical diseases and efforts to eliminate them. More than 1 billion people on the planet suffer from illnesses that the world pays little attention to. Neglected tropical diseases are a group of at least 18 diseases that primarily affect people living in poverty in tropical regions of the world and are virtually unknown elsewhere, according to the World Health Organization. These are diseases like river blindness, which has infected 18 million people worldwide and caused blindness in 270,000 people; or...
Source: Healthy Living - The Huffington Post - December 6, 2016 Category: Consumer Health News Source Type: news

18 Diseases The World Has Turned Its Back On
This article is part HuffPost’s Project Zero campaign, a yearlong series on neglected tropical diseases and efforts to eliminate them. More than 1 billion people on the planet suffer from illnesses that the world pays little attention to. Neglected tropical diseases are a group of at least 18 diseases that primarily affect people living in poverty in tropical regions of the world and are virtually unknown elsewhere, according to the World Health Organization. These are diseases like river blindness, which has infected 18 million people worldwide and caused blindness in 270,000 people; or...
Source: Science - The Huffington Post - December 6, 2016 Category: Science Source Type: news

Chagas Disease Screening in Umbilical Cord Blood Donors Chagas Disease Screening in Umbilical Cord Blood Donors
The identification of Chagas disease among cord blood donors highlights the importance of screening for this parasitic infection.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 18, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Bayer announces Phase III CHICO study of Nifurtimox to treat Chagas disease
Bayer has announced a Phase III CHICO study of Nifurtimox to treat children of all age groups with Chagas disease. (Source: Drug Development Technology)
Source: Drug Development Technology - November 16, 2016 Category: Pharmaceuticals Source Type: news

Seroprevalence and disease burden of chagas disease in south Texas
(PLOS) A paper published in PLOS Neglected Diseases led by researchers at the National School of Tropical Medicine at Baylor College of Medicine suggests that the disease burden in southern Texas is much higher than previously thought. Considering up to 30 percent of people infected with Trypanosoma cruzi can develop fatal cardiomyopathy, this study's findings carry important implications to the health of the population of south Texas. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 10, 2016 Category: Infectious Diseases Source Type: news

Plan of Action for the Elimination of Neglected Infectious Diseases and Post-Elimination Actions 2016-2022
World Health Organization, Pan American Health Organization. 07/07/2016 This 33-page document, prepared for the 68th Session of the Regional Committee of the World Health Organization for the Americas in September 2016, provides a six-year Plan of Action for neglected infectious diseases (NIDs) that proposes up-to-date lines of action to reduce morbidity, disability, and mortality; and to more rapidly advance efforts to eliminate NIDs as public health problems and stop NID transmission. It will address the surveillance, management, control, and elimination of 13 diseases: blinding trachoma, Chagas disease, cystic echinococ...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - October 1, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

New research reveals single class of drug could treat three neglected diseases
New research conducted by scientists from the University of York and Novartis has revealed that one drug might be able to treat three fatal and usually neglected parasitic diseases, Chagas disease, leishmaniasis and human African trypanosomiasis, als … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 9, 2016 Category: Pharmaceuticals Source Type: news

One drug is 'new hope' for three killer infections
A single drug can treat three deadly and neglected infections - Chagas disease, leishmaniasis and sleeping sickness - animal studies show.. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 9, 2016 Category: Consumer Health News Source Type: news